Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Add-on in Bipolar I Disorder
NCT00237289Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in bipolar I disorder, sponsored by Johnson & Johnson. Started Oct 2001; status: completed.
02
Drugs
topiramate
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00237289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237289.